BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 6295909)

  • 1. Relationship of pretransplant hepatobiliary disease to bile duct damage occurring in the liver allograft.
    Fennell RH; Shikes RH; Vierling JM
    Hepatology; 1983; 3(1):84-9. PubMed ID: 6295909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts.
    Vierling JM; Fennell RH
    Hepatology; 1985; 5(6):1076-82. PubMed ID: 3905558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destructive intrahepatic bile duct diseases.
    Desmet VJ
    Recenti Prog Med; 1990 Jun; 81(6):392-8. PubMed ID: 2251446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathology of primary biliary cirrhosis and autoimmune cholangitis.
    Ludwig J
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):601-13. PubMed ID: 10976017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.
    Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM
    Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis.
    Nakanuma Y
    Hepatology; 1993 Sep; 18(3):570-5. PubMed ID: 8359797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are bile duct lesions of primary biliary cirrhosis distinguishable from those of autoimmune hepatitis and chronic viral hepatitis? Interobserver histological agreement on trimmed bile ducts.
    Zen Y; Harada K; Sasaki M; Tsuneyama K; Matsui K; Haratake J; Sakisaka S; Maeyama S; Yamamoto K; Nakano M; Shimamatsu K; Kage M; Kurose N; Uchiyama A; Kaizaki Y; Toda G; Nakanuma Y
    J Gastroenterol; 2005 Feb; 40(2):164-70. PubMed ID: 15770400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies.
    Kaji K; Nakanuma Y; Sasaki M; Unoura M; Kobayashi K; Nonomura A; Tsuneyama K; Van de Water J; Gershwin ME
    Mod Pathol; 1994 Dec; 7(9):937-45. PubMed ID: 7892163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis.
    Ludwig J; Wiesner RH; LaRusso NF
    J Hepatol; 1988 Oct; 7(2):193-9. PubMed ID: 3057064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apoptosis protector, bcl-2 protein, is downregulated in bile duct epithelial cells of human liver allografts.
    Gapany C; Zhao M; Zimmermann A
    J Hepatol; 1997 Mar; 26(3):535-42. PubMed ID: 9075660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology.
    Ludwig J; Czaja AJ; Dickson ER; LaRusso NF; Wiesner RH
    Liver; 1984 Apr; 4(2):105-16. PubMed ID: 6727581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliary cirrhosis.
    Graham RP; Smyrk TC; Zhang L
    Am J Surg Pathol; 2012 May; 36(5):732-6. PubMed ID: 22498823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.
    Duclos-Vallee JC; Sebagh M
    Liver Transpl; 2009 Nov; 15 Suppl 2():S25-34. PubMed ID: 19876939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors.
    Oguma S; Belle S; Starzl TE; Demetris AJ
    Hepatology; 1989 Feb; 9(2):204-9. PubMed ID: 2643544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis.
    Wiesner RH; LaRusso NF; Ludwig J; Dickson ER
    Gastroenterology; 1985 Jan; 88(1 Pt 1):108-14. PubMed ID: 3880553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune disorders of the liver and bile duct.
    Vierling JM
    Gastroenterol Clin North Am; 1992 Jun; 21(2):427-49. PubMed ID: 1512050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis.
    Washington K; Clavien PA; Killenberg P
    Hum Pathol; 1997 Jul; 28(7):791-5. PubMed ID: 9224746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The syndrome of disappearing intrahepatic bile ducts.
    Sherlock S
    Lancet; 1987 Aug; 2(8557):493-6. PubMed ID: 2887786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenobiotic-induced liver injury and fibrosis.
    Österreicher CH; Trauner M
    Expert Opin Drug Metab Toxicol; 2012 May; 8(5):571-80. PubMed ID: 22452290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.